These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34220820)

  • 1. A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.
    Strubbe S; De Bruyne M; Pannicke U; Beyls E; Vandekerckhove B; Leclercq G; De Baere E; Bordon V; Vral A; Schwarz K; Haerynck F; Taghon T
    Front Immunol; 2021; 12():674226. PubMed ID: 34220820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
    Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
    J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
    Mou W; Gao L; He J; Yin J; Xu B; Gui J
    Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
    Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
    Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
    Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
    Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
    Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
    Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Genetic Characterization of Patients with Artemis Deficiency in Japan.
    Inoue K; Miyamoto S; Tomomasa D; Adachi E; Azumi S; Horikoshi Y; Ishihara T; Osone S; Kawahara Y; Kudo K; Kato Z; Ohnishi H; Kashimada K; Imai K; Ohara O; van Zelm MC; Cowan MJ; Morio T; Kanegane H
    J Clin Immunol; 2023 Apr; 43(3):585-594. PubMed ID: 36385359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow.
    Noordzij JG; Verkaik NS; van der Burg M; van Veelen LR; de Bruin-Versteeg S; Wiegant W; Vossen JM; Weemaes CM; de Groot R; Zdzienicka MZ; van Gent DC; van Dongen JJ
    Blood; 2003 Feb; 101(4):1446-52. PubMed ID: 12406895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
    Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
    Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and mechanistic insights into the Artemis endonuclease and strategies for its inhibition.
    Yosaatmadja Y; Baddock HT; Newman JA; Bielinski M; Gavard AE; Mukhopadhyay SMM; Dannerfjord AA; Schofield CJ; McHugh PJ; Gileadi O
    Nucleic Acids Res; 2021 Sep; 49(16):9310-9326. PubMed ID: 34387696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual phenotype in patients with a hypomorphic mutation in the DCLRE1C gene: IgG hypergammaglobulinemia with IgA and IgE deficiency.
    Nahum A; Somech R; Shubinsky G; Levy J; Broides A
    Clin Immunol; 2020 Apr; 213():108366. PubMed ID: 32092471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.
    Volk T; Pannicke U; Reisli I; Bulashevska A; Ritter J; Björkman A; Schäffer AA; Fliegauf M; Sayar EH; Salzer U; Fisch P; Pfeifer D; Di Virgilio M; Cao H; Yang F; Zimmermann K; Keles S; Caliskaner Z; Güner SÜ; Schindler D; Hammarström L; Rizzi M; Hummel M; Pan-Hammarström Q; Schwarz K; Grimbacher B
    Hum Mol Genet; 2015 Dec; 24(25):7361-72. PubMed ID: 26476407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital defects in V(D)J recombination.
    de Villartay JP
    Br Med Bull; 2015 Jun; 114(1):157-67. PubMed ID: 25987660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans.
    Li L; Moshous D; Zhou Y; Wang J; Xie G; Salido E; Hu D; de Villartay JP; Cowan MJ
    J Immunol; 2002 Jun; 168(12):6323-9. PubMed ID: 12055248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
    Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
    Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination events.
    Pannicke U; Hönig M; Schulze I; Rohr J; Heinz GA; Braun S; Janz I; Rump EM; Seidel MG; Matthes-Martin S; Soerensen J; Greil J; Stachel DK; Belohradsky BH; Albert MH; Schulz A; Ehl S; Friedrich W; Schwarz K
    Hum Mutat; 2010 Feb; 31(2):197-207. PubMed ID: 19953608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3ε
    Boettcher AN; Cino-Ozuna AG; Solanki Y; Wiarda JE; Putz E; Owens JL; Crane SA; Ahrens AP; Loving CL; Cunnick JE; Rowland RRR; Charley SE; Dekkers JCM; Tuggle CK
    Front Immunol; 2020; 11():510. PubMed ID: 32296428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new gene involved in DNA double-strand break repair and V(D)J recombination is located on human chromosome 10p.
    Moshous D; Li L; Chasseval R; Philippe N; Jabado N; Cowan MJ; Fischer A; de Villartay JP
    Hum Mol Genet; 2000 Mar; 9(4):583-8. PubMed ID: 10699181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational landscape of severe combined immunodeficiency patients from Turkey.
    Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
    Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.
    Moshous D; Callebaut I; de Chasseval R; Corneo B; Cavazzana-Calvo M; Le Deist F; Tezcan I; Sanal O; Bertrand Y; Philippe N; Fischer A; de Villartay JP
    Cell; 2001 Apr; 105(2):177-86. PubMed ID: 11336668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.